Alison Bryant

Articles by Alison Bryant

CDC notes few elderly got Sanofi high-dose flu vax in tough year

Low efficacy of this season's flu vaccine highlights the need for vaccinemakers to develop a better, longer-lasting shot. Only 56% of people who received the jab were protected from influenza, the U.S. Centers for Disease Control and Prevention reports, and the elderly were among the least shielded.

After rejection, Dynavax to shoot for limited hep B vaccine approval

After rejecting Dynavax's ($DVAX) hepatitis B vaccine Heplisav for safety issues, the FDA said it will meet with the company in 6 weeks' time to discuss a more restricted use of the vaccine.

Rising vaccine prices mean fewer children immunized

Adding more children's vaccines to the recommended package should--in theory--save more lives. But rising prices may actually mean fewer children are vaccinated.

NIH-funded researchers test Shigella vaccine

National Institutes of Health-funded researchers aim to put a stop to Shigella, an illness found most commonly in children, with two related vaccine candidates.

Indian court: Sanofi doesn't owe taxes on Shantha merger

An Indian high court on Friday quashed India's income tax department's claim that Sanofi owed more than $185 million in capital gains tax in relation to its 2009 buyout of Shantha Biotechnics.

Universal flu vaccine still 5 to 10 years away

Though the United States has made significant progress in the realm of flu vaccines, the country will likely need to wait 5 to 10 years for a universal shot, top federal health officials said.

HealthMap helps patients locate nearby vaccination sites

Computer technology is being used more widely in upping vaccination rates worldwide. A team of researchers, epidemiologists and software developers at Boston Children's Hospital rolled out a free online service that helps people locate nearby vaccine providers in an effort to boost immunization numbers.

Australia begins vaccinating boys for HPV

On Feb. 15, Australian boys began receiving Gardasil as part of a $21 million program geared toward vaccinating 12- and 13-year-olds.

Jennerex therapy shrinks tumors in liver cancer patients

Jennerex's genetically modified smallpox vaccine shrunk tumors in liver cancer patients and extended survival by more than a year, a study shows.

New whooping cough strain may resist vaccine

Researchers have discovered cases of whooping cough caused by a germ that may stand up to the vaccine.